T 細胞治療市場,按治療類型、適應症、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1364703

T 細胞治療市場,按治療類型、適應症、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

T-Cell Therapy Market, By Therapy Type, By Indication, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年 T 細胞治療市場規模為 27.086 億美元,2023 年至 2030 年年複合成長率為 34.9%。

T細胞治療市場-市場動態

對開發治療疾病的新療法的日益關注預計將推動 T 細胞治療市場的成長。

隨著全球疾病(特別是癌症)盛行率的上升,迫切需要更有效和量身定做的治療方法。據美國國家癌症研究所稱,到 2023 年,美國將有大約 200 萬人被診斷出患有癌症。估計有 297,790 名女性和 2,800 名男性將被診斷出患有乳癌,這使其成為最常見的癌症診斷。 T 細胞治療正在成為一種可行的治療選擇,特別是對於患有抗藥性或復發性疾病的個體。鑑於 T 細胞治療的潛力,人們在研究和開發方面投入了大量資金。此外,推動新型生物療法的研究以及增加生物製劑的供應和安全性預計將為 T 細胞療法市場提供成長機會。然而,嚴重危及生命的毒性、適度的抗腫瘤活性、抗原逃脫、運輸受限和腫瘤浸潤有限是限制市場成長的因素。

T 細胞治療市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析,預計全球 T 細胞治療市場在預測期內(2023-2030 年)每年將以 34.9% 左右的年複合成長率成長
  • 由於癌症負擔不斷增加以及 T 細胞療法的研發不斷增加,T 細胞療法產業預計將快速成長。
  • 根據治療類型細分,預計 CAR T 細胞療法將在 2022 年顯示最大的市場佔有率
  • 根據適應症細分,血液系統惡性腫瘤是2022年的主導類型
  • 按地區分類,北美是 2022 年的主要收入來源

T 細胞治療市場-細分分析:

全球 T 細胞治療市場根據治療類型、適應症和區域進行細分。

根據治療類型,市場分為三類: CAR T細胞療法、基於細胞受體(TCR)的療法和基於腫瘤浸潤淋巴細胞(TIL)的療法。 CAR T 細胞治療領域預計將主導市場成長。 CAR-T 療法是 T 細胞療法的一種,其中 T 細胞經過基因工程改造,表達可特異性靶向癌細胞的受體 (CAR)。

根據適應症,市場分為兩類:血液惡性腫瘤、實體腫瘤和其他。血液惡性腫瘤主導著市場成長。 CAR-T細胞免疫療法被廣泛認為是急性淋巴性白血病(ALL)、多發性骨髓瘤(MM)、慢性淋巴球白血病(CLL)、急性骨髓性白血病(AML)、何杰金氏淋巴瘤等血液系統惡性腫瘤患者的重要治療選擇。淋巴瘤(HL)和非何杰金氏淋巴瘤(NHL)。

T 細胞治療市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。由於越來越多的製藥公司專注於開發過繼療法,預計北美將主導市場的成長,北美,特別是美國,擁有無數的生物技術新創公司、著名的研究機構和一些世界上最大的製藥公司。這些組織積極投資並推動新型療法的利潤,例如過繼性 T 細胞療法。例如,Fate Therapeutics, Inc是一家臨床階段的生物製藥公司,致力於為癌症患者開發程序化細胞免疫療法,該公司展示了幾種旨在實現現成的基於細胞的癌症免疫療法的新策略的臨床前資料在第 64 屆美國血液學會 (ASH) 年會暨博覽會上,無需進行預處理化療。

製藥業仍然是創新的溫床,新治療模式的發展、未滿足的需求的嚴重性以及藥物基因組學、數位療法和人工智慧等技術的重要性日益增加,推動了製藥業的活動。此外,由於與嵌合抗原受體(CAR)-T細胞療法和T細胞受體(TCR)等T細胞療法相關的產品批准不斷成長,預計歐洲和亞太地區將推動T細胞療法市場的顯著成長-基於和基於腫瘤浸潤淋巴細胞(TIL)。

T細胞治療市場-競爭格局:

一些新的市場參與者正在推動 T 細胞治療領域的創新。一些公司專注於下一代 CAR-T 療法,而其他公司則正在研究替代細胞類型、更安全的設計或削減成本的策略。此外,新型CAR-T療法的強勁發展也體現在企業積極利用智慧財產權以及大量的研發投入。製造商展示了CAR-T技術的專利和臨床概況,涵蓋目前的臨床試驗環境、尖端的CAR相關發明、主要參與者以及它們如何相互作用以產生新技術。此外,T 細胞治療最初更集中於北美和歐洲部分地區等地區。亞太地區、拉丁美洲和中東的監管批准可以開闢大型新市場,隨著企業擴大業務範圍增加需求。

最近的發展:

2019 年10 月,領先的科技公司默克宣布收購了位於美國馬薩諸塞州威爾布拉漢姆的FloDesign Sonics,該公司開發了一種獨特的聲學細胞處理平台,用於細胞和基因治療製造的工業化。財務細節並未揭露。

目錄

第一章:T 細胞治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按治療類型分類的 T 細胞治療市場片段
    • 按適應症分類的 T 細胞治療市場片段
    • 按國家/地區分類的 T 細胞治療市場片段
    • 按地區分類的 T 細胞治療市場片段
  • 競爭洞察

第 3 章:T 細胞治療主要市場趨勢

  • T 細胞治療市場促進因素
    • 市場促進因素的影響分析
  • T細胞治療市場限制
    • 市場限制影響分析
  • T 細胞治療市場機會
  • T細胞治療市場未來趨勢

第 4 章:T 細胞治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:T 細胞治療市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章:T 細胞治療市場格局

  • 2022 年 T 細胞治療市佔分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章:T 細胞治療市場 - 依治療類型

  • 概述
    • 按治療類型分類的細分市場佔有率分析
    • CAR T細胞療法
    • 基於 T 細胞受體 (TCR)
    • 基於腫瘤浸潤淋巴細胞 (TIL)

第 8 章:T 細胞治療市場 - 依適應症分類

  • 概述
    • 按指標分類的細分市場佔有率分析
    • 血液系統惡性腫瘤
    • 實體腫瘤
    • 其他

第 9 章:T 細胞治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美 T 細胞療法主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按治療類型)
    • 北美市場規模和預測(按指標)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲 T 細胞療法主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模和預測(按治療類型)
    • 歐洲市場規模與預測(按指標)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區 T 細胞療法主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按治療類型)
    • 亞太地區市場規模與預測(依指標)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲 T 細胞療法主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按治療類型)
    • 拉丁美洲市場規模與預測(按指標)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲 T 細胞療法主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模和預測(按治療類型)
    • 中東和非洲市場規模及預測(依指標)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章:主要供應商分析 - T 細胞治療產業

  • 競爭儀表板
  • 公司簡介
    • Novartis AG
    • Merck KGaA
    • Gilead Sciences Inc.
    • TCR2 Therapeutics Inc
    • Bluebird Bio Inc.
    • Sorrento Therapeutics
    • Fate Therapeutics
    • Pfizer Inc.
    • Amgen
    • Celgene Corporation

第 11 章:360 度分析師視角

第 12 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1751

REPORT HIGHLIGHT

T-Cell Therapy Market size was valued at USD 2,708.6 Million in 2022, expanding at a CAGR of 34.9% from 2023 to 2030.

T-cell therapy is a form of immunotherapy in which T-cells, a type of white blood cell, are used to treat specific disorders, most notably cancer. There are two main types of T-cell transfer therapy tumor-infiltrating lymphocytes (or TIL) therapy and CAR T-cell therapy. T-cell transfer therapy was initially investigated for the treatment of metastatic melanoma since melanomas frequently cause a robust immune response and have a high number of TILs. TIL treatment has been shown to be successful in some cases of melanoma and has achieved encouraging results in other cancers such as cervical squamous cell carcinoma and cholangiocarcinoma. However, T-cell therapy is a key advancement in cancer treatment. Conversely, like many medicines, it comes with both enormous promise and significant challenges. There is continuing research to increase the efficacy, safety, and accessibility of these medicines.

T-Cell Therapy Market- Market Dynamics

The rising focus on Developing new therapies for the treatment of diseases is expected to drive the growth of the T-cell therapy market.

As the global prevalence of diseases, particularly cancer, rises, there is an urgent requirement for more effective and tailored therapies. According to the National Cancer Institute, in 2023, roughly 2.0 million people will be diagnosed with cancer in the United States. An estimated 297,790 women and 2,800 men will be diagnosed with breast cancer, which makes it the most common cancer diagnosis. T-cell treatments are emerging as a viable treatment option, particularly for individuals suffering from resistant or recurrent diseases. Given the potential of T-cell treatments, enormous investment has been made in research and development. Furthermore, advancing research on novel biotherapies and increasing the supply and safety of biologics are the factors that are expected to provide growth opportunities for the T-cell therapy market. However, severe life-threatening toxicities, modest anti-tumor activity, antigen escape, restricted trafficking, and limited tumor infiltration are the factors that restrict the growth of the market.

T-Cell Therapy Market- Key Insights

  • As per the analysis shared by our research analyst, the global T-Cell Therapy market is estimated to grow annually at a CAGR of around 34.9% over the forecast period (2023-2030)
  • The T-cell therapy industry is expected to grow at a rapid pace due to the rising cancer burden and increased research and development to create T-cell therapy.
  • Based on Therapy type segmentation, CAR T-cell Therapy was predicted to show maximum market share in the year 2022
  • Based on Indication segmentation, Hematologic Malignancies was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

T-Cell Therapy Market- Segmentation Analysis:

The Global T-Cell Therapy Market is segmented on the basis of Therapy Type, Indication, and Region.

The market is divided into three categories based on Therapy type: CAR T-cell Therapy, Cell Receptor (TCR)-based, and Tumor Infiltrating Lymphocytes (TIL)-based. CAR T-cell Therapy segment is expected to dominate the market growth. CAR-T therapy is a type of T-cell therapy in which T-cells are genetically engineered to express a receptor (the CAR) that can specifically target cancer cells.

The market is divided into two categories based on Indication: Hematologic Malignancies, Solid Tumors, and Others. Hematologic Malignancies dominate the market growth. CAR-T-cell immunotherapy is widely recognized as an important treatment option for patients suffering from hematological malignancies such as acute lymphoblastic leukemia (ALL), multiple myeloma (MM), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), Hodgkin lymphoma (HL), and non-Hodgkin lymphoma (NHL).

T-Cell Therapy Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to the increasing number of pharmaceutical companies focusing on developing adoptive therapies, North America, particularly the United States, is host to a myriad of biotech startups, prestigious research institutions, and some of the world's largest pharmaceutical companies. These organizations actively invest in and push the margins of novel therapeutics, such as adoptive T-cell therapy. For example, Fate Therapeutics, Inc, a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, presented preclinical data of several novel strategies designed to enable the administration of off-the-shelf cell-based cancer immunotherapies without conditioning chemotherapy at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition.

The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet need, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. Furthermore, Europe and Asia Pacific are expected to propel significant growth in T-cell therapy Market, due to the Growing Product Approvals Associated with T-cell therapies like Chimeric antigen receptor (CAR)-T cell therapy and T Cell Receptor (TCR)-based and Tumor Infiltrating Lymphocytes (TIL)-based.

T-Cell Therapy Market- Competitive Landscape:

Several new market players are driving innovation in the field of T-cell therapy. Some are concentrating on next-generation CAR-T therapy, while others are investigating alternate cell types, safer designs, or cost-cutting strategies. Also, the robust development of new CAR-T therapies is characterized by the active use of intellectual property rights by firms, as well as substantial R&D investments. Manufacturers exhibit CAR-T technologies' patent and clinical landscape, covering the current clinical trial environment, cutting-edge CAR-related inventions, the main actors, and how they interact with one another to generate new technologies. Furthermore, T-cell treatments were initially more focused in regions such as North America and parts of Europe. Regulatory approvals in Asia-Pacific, Latin America, and the Middle East can open up large new markets, raising demand as corporations expand their reach.

Recent Developments:

In October 2019, Merck, a leading science and technology company, nowadays announced it had acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL T-CELL THERAPY MARKET KEY PLAYERS

  • Novartis AG
  • Merck KGaA
  • Gilead Sciences Inc.
  • TCR2 Therapeutics Inc
  • Bluebird Bio Inc.
  • Sorrento Therapeutics
  • Fate Therapeutics
  • Pfizer Inc.
  • Amgen
  • Celgene Corporation

GLOBAL T-CELL THERAPY MARKET, BY THERAPY TYPE

  • CAR T-cell Therapy
  • T Cell Receptor (TCR)-based
  • Tumor Infiltrating Lymphocytes (TIL)-based

GLOBAL T-CELL THERAPY MARKET, BY INDICATION

  • Hematologic Malignancies
  • Solid Tumors
  • Others

GLOBAL T-CELL THERAPY MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. T-Cell Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. T-Cell Therapy Market Snippet by Therapy Type
    • 2.1.2. T-Cell Therapy Market Snippet by Indication
    • 2.1.3. T-Cell Therapy Market Snippet by Country
    • 2.1.4. T-Cell Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. T-Cell Therapy Key Market Trends

  • 3.1. T-Cell Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. T-Cell Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. T-Cell Therapy Market Opportunities
  • 3.4. T-Cell Therapy Market Future Trends

4. T-Cell Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. T-Cell Therapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. T-Cell Therapy Market Landscape

  • 6.1. T-Cell Therapy Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. T-Cell Therapy Market - By Therapy Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
    • 7.1.2. CAR T-cell Therapy
    • 7.1.3. T Cell Receptor (TCR)-based
    • 7.1.4. Tumor Infiltrating Lymphocytes (TIL)-based

8. T-Cell Therapy Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 8.1.2. Hematologic Malignancies
    • 8.1.3. Solid Tumors
    • 8.1.4. Others

9. T-Cell Therapy Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. T-Cell Therapy Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. T-Cell Therapy Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. T-Cell Therapy Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. T-Cell Therapy Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. T-Cell Therapy Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- T-Cell Therapy Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Novartis AG
    • 10.2.2. Merck KGaA
    • 10.2.3. Gilead Sciences Inc.
    • 10.2.4. TCR2 Therapeutics Inc
    • 10.2.5. Bluebird Bio Inc.
    • 10.2.6. Sorrento Therapeutics
    • 10.2.7. Fate Therapeutics
    • 10.2.8. Pfizer Inc.
    • 10.2.9. Amgen
    • 10.2.10. Celgene Corporation

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE T-Cell Therapy Market: Therapy Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapy Type
  • TABLE Global T-Cell Therapy Market, by Therapy Type 2018-2030 (USD Million)
  • TABLE T-Cell Therapy Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global T-Cell Therapy Market, by Indication 2018-2030 (USD Million)
  • TABLE T-Cell Therapy Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global T-Cell Therapy Market, by Region 2018-2030 (USD Million)
  • TABLE North America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE North America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE North America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Europe T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Latin America T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa T-Cell Therapy Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa T-Cell Therapy Market, by Therapy Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa T-Cell Therapy Market, by Indication, 2018-2030 (USD Million)

List of Figures

  • FIGURE T-Cell Therapy Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Therapy Type segment market share analysis, 2022 & 2030
  • FIGURE Therapy Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America T-Cell Therapy Market share and leading players, 2022
  • FIGURE Europe T-Cell Therapy Market share and leading players, 2022
  • FIGURE Asia Pacific T-Cell Therapy Market share and leading players, 2022
  • FIGURE Latin America T-Cell Therapy Market share and leading players, 2022
  • FIGURE Middle East and Africa T-Cell Therapy Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe T-Cell Therapy Market share analysis by country, 2022
  • FIGURE Germany T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific T-Cell Therapy Market share analysis by country, 2022
  • FIGURE India T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America T-Cell Therapy Market share analysis by country, 2022
  • FIGURE Brazil T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa T-Cell Therapy Market share analysis by country, 2022
  • FIGURE Saudi Arabia T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA T-Cell Therapy Market size, forecast and trend analysis, 2018 to 2030 (USD Million)